PURIFICATION AND APPLICATION OF FACTOR, CONTRIBUTING TO WOUND HEALING Russian patent published in 2014 - IPC C07K1/14 C07K1/18 C07K1/22 C07K1/34 C07K1/36 A61K38/17 A61K38/18 A61K38/36 A61K35/14 A61P17/02 

Abstract RU 2520817 C2

FIELD: chemistry.

SUBSTANCE: group of inventions relates to the field of biotechnology. Claimed is a method of purification of a factor, contributing to wound healing, which represents a hepatocyte growth factor (HGF). All stages of purification are carried out in the presence of antithrombin III (AT-III). In accordance with the claimed method carried out are: defrosting of the frozen HGF-containing source and removal of sediment from the defrosted source. After that, the obtained solution, which contains a supernatant and AT-III, is brought in contact with a carrier for affinity chromatography on an immobilised heparin. Then, the solution is separated from the carrier for affinity chromatography. The carrier is brought in contact with a desorption buffer with ionic strength sufficient for HGF desorption. The desorption buffer, containing HGF, AT-III and histidine-rich glycoprotein (HRGP) is collected. Also claimed are wound-healing compositions, which contain HGF, AT-III and/or HRGP, purified by the claimed method.

EFFECT: inventions make it possible to increase step-by-step output of the hepatocyte growth factor, with the hepatocyte growth factor being concentrated in eluate in the presence of AT-III.

26 cl, 2 tbl, 6 ex

Similar patents RU2520817C2

Title Year Author Number
METHOD OF ANTITROMBIN III MEDICATION PREPARATION OF HUMAN PLASMA 2008
  • Igonin Anton Alekseevich
  • Uvarov Valentin Jur'Evich
  • Pal'Tseva Ekaterina Mikhajlovna
  • Ivanov Aleksej Alekseevich
  • Berkovskij Aron Leonidovich
RU2357742C1
METHODS FOR REDUCING AND/OR REMOVING FXI AND FXIA FROM SOLUTIONS CONTAINING SAID CLOTTING FACTORS 2011
  • Shultts, Petra
  • Gruber, Gerkhard
  • Bal, Frederik
  • Marks, Frank
  • Vinge, Stefan
RU2649363C2
REDUCING CONTENT OF PROTEIN CONTAMINANTS IN COMPOSITIONS CONTAINING VITAMIN K-DEPENDENT PROTEIN OF INTEREST 2005
  • Krarup Janus
  • Khansen Tomas Budde
  • Arentsen Anne Sharlott
  • Rasmussen Deniel E.
  • Bognes Are
  • Stabi Arne
  • Akhmadian Khale
  • Bang Sjuzann
RU2460735C2
ACTIVATING DEVICE AND ACTIVATION METHOD FOR DUAL BATTERY SYSTEM 2011
  • Ledfel'T, Gunnar
RU2536163C1
METHOD FOR PURIFYING VITAMIN K DEPENDENT PROTEINS SUCH AS COAGULATION FACTOR IX 2011
  • Gillyam Gustav
  • Vinge Stefan
RU2590726C2
METHOD OF PURIFYING VITAMIN K-DEPENDENT PROTEINS, SUCH AS COAGULATION FACTOR VII 2011
  • Gillyam Gustav
  • Vinge Stefan
RU2731720C2
METHOD FOR CLEANING FIBRINOGEN, FIBRINOGEN PRODUCT AND MEANS FOR CLEANING OR PRODUCING FIBRINOGEN PRODUCT 2013
  • Shults Petra
  • Geringer Verner
  • Pape Rajner
  • Remish Yurgen
  • Lyajtinger Karoline
  • Shen Fridrikh
RU2663792C2
METHOD OF SEPARATING AND PURIFYING TARGET PROTEIN WITHOUT ADMIXTURE OF PRION PROTEIN PrP 2008
  • Gill'Jam Gustav
  • Jernberg Mats
  • Vinge Stefan
  • Najsser-Svae Andrea
RU2491292C2
IMPROVING IMMUNOGLOBULIN AFFINITY CHROMATOGRAPHY BY THE APPLICATION OF PRE-CAPTURE FLOCULATION 2020
  • Keszey, Zsuzsanna
  • Suto, Zoltan
RU2794431C1
METHOD OF PRODUCING FACTOR VIII, HAVING IMPROVED RATIO FVIII:C/FVIII:AG 2015
  • Vinge Stefan
  • Dadayan Marina
  • Jokhansson Erika
  • Fuks Birte
RU2695428C2

RU 2 520 817 C2

Authors

Najsser-Sve Andrea

Vinge Stefan

M'Erdestam Anna

Dates

2014-06-27Published

2007-01-25Filed